| JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 49,63% | 22,83% | -22,71% | · |
| JUPITER ASIA PACIFIC INCOME FUND (IRL) C USD CAP | RVI ASIA EX-JAPÓN | 49,63% | 80,57% | 51,50% | 136,68% |
| FIDELITY FUNDS 2 - TRANSITION MATERIALS Y-ACC USD | RVI MATERIAS PRIMAS | 49,62% | · | · | · |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 49,60% | 22,80% | -22,74% | · |
| LABORAL KUTXA BOLSA JAPON, FI | RVI JAPÓN | 49,60% | 82,61% | 89,10% | 187,37% |
| ALLIANZ JAPAN EQUITY AT (H-EUR) EUR | RVI JAPÓN | 49,58% | 96,05% | 134,32% | 254,43% |
| BGF WORLD GOLD A2 PLN (HEDGED) | RVI MATERIAS PRIMAS | 49,58% | 179,36% | 131,14% | · |
| ROBECO EMERGING MARKETS EQUITIES I EUR | RVI EMERGENTES | 49,58% | 80,77% | 61,64% | 186,38% |
| DWS ESG BIOTECH FC | RVI BIOTECNOLOGÍA | 49,56% | 50,79% | 39,10% | · |
| SCHRODER ISF ASIAN TOTAL RETURN B ACC USD | RVI ASIA PACÍFICO | 49,56% | 75,86% | 51,33% | 165,78% |
